Hepatocellular Carcinoma
Conference Coverage
Drug combo improves recurrence-free survival after HCC resection
Study shows significant improvement in recurrence-free survival with atezolizumab and bevacizumab combo.
Original Research
Psychosocial Barriers and Their Impact on Hepatocellular Carcinoma Care in US Veterans: Tumor Board Model of Care
Individualizing care, and coordination of travel and lodging, contributed to high rates of hepatocellular carcinoma–specific therapy and improved...
Roundtables
HCC: first line treatment considerations and managing toxicities
Original Research
Antiviral Therapy Improves Hepatocellular Cancer Survival
Treatment of hepatitis C virus infection leads to overall survival benefit particularly among patients who achieve sustained virologic response...